Cargando…
GPCRs Revisited: New Insights Lead to Novel Drugs
GPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053956/ http://dx.doi.org/10.3390/ph4020244 |
_version_ | 1782320475952644096 |
---|---|
author | Eglen, Richard M. Reisine, Terry |
author_facet | Eglen, Richard M. Reisine, Terry |
author_sort | Eglen, Richard M. |
collection | PubMed |
description | GPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies such as allosteric regulators as well pepducins, that affect the interaction of GPCRs with G proteins, to either block selective receptor signaling pathways or mimic the actions of intracellular domains of receptors, thereby activating GPCRs to signal selectively to intracellular pathways. We will review these new concepts and then discuss how they may be exploited using modern discovery technologies to provide novel drug candidates for the future. |
format | Online Article Text |
id | pubmed-4053956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-40539562014-06-12 GPCRs Revisited: New Insights Lead to Novel Drugs Eglen, Richard M. Reisine, Terry Pharmaceuticals (Basel) Review GPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies such as allosteric regulators as well pepducins, that affect the interaction of GPCRs with G proteins, to either block selective receptor signaling pathways or mimic the actions of intracellular domains of receptors, thereby activating GPCRs to signal selectively to intracellular pathways. We will review these new concepts and then discuss how they may be exploited using modern discovery technologies to provide novel drug candidates for the future. MDPI 2011-01-25 /pmc/articles/PMC4053956/ http://dx.doi.org/10.3390/ph4020244 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Eglen, Richard M. Reisine, Terry GPCRs Revisited: New Insights Lead to Novel Drugs |
title | GPCRs Revisited: New Insights Lead to Novel Drugs |
title_full | GPCRs Revisited: New Insights Lead to Novel Drugs |
title_fullStr | GPCRs Revisited: New Insights Lead to Novel Drugs |
title_full_unstemmed | GPCRs Revisited: New Insights Lead to Novel Drugs |
title_short | GPCRs Revisited: New Insights Lead to Novel Drugs |
title_sort | gpcrs revisited: new insights lead to novel drugs |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053956/ http://dx.doi.org/10.3390/ph4020244 |
work_keys_str_mv | AT eglenrichardm gpcrsrevisitednewinsightsleadtonoveldrugs AT reisineterry gpcrsrevisitednewinsightsleadtonoveldrugs |